Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-08 @ 9:32 PM
Study NCT ID:
NCT04179032
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-23
First Post:
2019-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-04-26
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-25
First Submit QC Date:
None
Study First Post Date:
2019-11-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-16
Results First Submit QC Date:
None
Results First Post Date:
2024-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-22
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED